Latest News

Our methodologists have contributed to updated guidelines to improve the transparency and quality of clinical trial reports and protocols .
Add-Aspirin has successfully completed recruitment and randomised 8,756 people who’d recently had, or are having, cancer treatment.
These findings will help inform international guidelines and support the development of new drug combinations for children worldwide.
The alternative strategies aim to make it easier for patients to access and adhere to curative treatment.
Comprehensively updated guidance and associated calculations spreadsheet are valuable new tools for all those conducting meta-analyses based on published time-to-event data.